Delivery Order SPE2DB22D2005-SPE2DB24FJNR7
- Not listed
- This federal contract award, valued at $5,805.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2025. This IDC...
- This federal contract award, valued at $14,028.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to treat Type 2 diabetes. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to...
- This federal contract award, valued at $2,902.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 4.5 mg/0.5 ml pens, a medication used for diabetes management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The contract is a firm fixed price delivery order, with a completion date of July 15, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies. The $6,993.36 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
- This federal contract award, valued at $2,280.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to $999,999,999.00, serves as...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,741.68 and a completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,327.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued up to $10,845.52, is a Delivery Order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to...
- This federal contract award, valued at $1,032.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract is a delivery order, with a firm fixed-price pricing type and an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJNR7Delivery Order
This federal contract award, valued at $2,902.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the delivery of Trulicity 1.5 mg/0.5 mL pens, a prescription medication used to treat type 2 diabetes. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/12/24 |